Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CYTRNASDAQ:FGMNASDAQ:FPANASDAQ:PCLA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCYTRLadRx$0.09$0.05▼$0.86$4.14MN/A99,706 shs4,000 shsFGMFirst Trust Germany AlphaDEX Fund$54.72-0.6%$49.21$35.02▼$55.72$16.42M1.117,709 shs13,518 shsFPAFirst Trust Asia Pacific ex-Japan AlphaDEX Fund$32.28+0.4%$29.61$24.19▼$32.79$16.14M12,307 shs1,355 shsPCLAPicocela$0.82+18.0%$0.58$0.37▼$9.80$18.81MN/A658,523 shs327,328 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCYTRLadRx0.00%0.00%0.00%0.00%0.00%FGMFirst Trust Germany AlphaDEX Fund-0.64%+1.11%+8.83%+24.90%+34.58%FPAFirst Trust Asia Pacific ex-Japan AlphaDEX Fund+0.40%+1.03%+8.18%+10.13%+16.16%PCLAPicocela+17.97%+49.61%+30.49%-85.44%+81,999,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCYTRLadRxN/AN/AN/AN/AN/AN/AN/AN/AFGMFirst Trust Germany AlphaDEX FundN/AN/AN/AN/AN/AN/AN/AN/AFPAFirst Trust Asia Pacific ex-Japan AlphaDEX FundN/AN/AN/AN/AN/AN/AN/AN/APCLAPicocelaN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCYTRLadRx 0.00N/AN/AN/AFGMFirst Trust Germany AlphaDEX Fund 0.00N/AN/AN/AFPAFirst Trust Asia Pacific ex-Japan AlphaDEX Fund 0.00N/AN/AN/APCLAPicocela 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCYTRLadRxN/AN/AN/AN/AN/AN/AFGMFirst Trust Germany AlphaDEX FundN/AN/AN/AN/AN/AN/AFPAFirst Trust Asia Pacific ex-Japan AlphaDEX FundN/AN/AN/AN/AN/AN/APCLAPicocela$784.40M0.02N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCYTRLadRxN/AN/A0.00N/AN/AN/AN/AN/AN/AFGMFirst Trust Germany AlphaDEX FundN/AN/A13.17∞N/AN/AN/AN/AN/AFPAFirst Trust Asia Pacific ex-Japan AlphaDEX FundN/AN/A11.22∞N/AN/AN/AN/AN/APCLAPicocelaN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCYTRLadRxN/AN/AN/AN/AN/AFGMFirst Trust Germany AlphaDEX Fund$0.831.52%N/AN/AN/AFPAFirst Trust Asia Pacific ex-Japan AlphaDEX Fund$1.013.13%N/AN/AN/APCLAPicocelaN/AN/AN/AN/AN/ALatest CYTR, FGM, PCLA, and FPA DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/26/2025FPAFirst Trust Asia Pacific ex-Japan AlphaDEX FundQuarterly$0.20162.78%3/27/20253/27/20253/31/2025(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCYTRLadRxN/AFGMFirst Trust Germany AlphaDEX FundN/AFPAFirst Trust Asia Pacific ex-Japan AlphaDEX FundN/APCLAPicocelaN/AInsider OwnershipCompanyInsider OwnershipCYTRLadRxN/AFGMFirst Trust Germany AlphaDEX FundN/AFPAFirst Trust Asia Pacific ex-Japan AlphaDEX FundN/APCLAPicocelaN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCYTRLadRxN/A45.04 millionN/ANot OptionableFGMFirst Trust Germany AlphaDEX Fund147,000300,000N/ANot OptionableFPAFirst Trust Asia Pacific ex-Japan AlphaDEX Fund147,000500,000N/ANot OptionablePCLAPicocela5322.93 millionN/AN/ACYTR, FGM, PCLA, and FPA HeadlinesRecent News About These CompaniesPicoCELA Inc. Issues Restricted Common Shares to Nikken Lease Kogyo Co. Ltd.May 1, 2025 | prnewswire.comPicoCELA Inc. Receives Nasdaq Notification Regarding Minimum Bid Price DeficiencyApril 24, 2025 | prnewswire.comPicoCELA Inc. American Depositary Shares (PCLA) Institutional HoldingsMarch 30, 2025 | nasdaq.comPicoCELA files to sell 6.1M American Depositary SharesMarch 13, 2025 | markets.businessinsider.comPicocela Inc ADR (PCLA)February 22, 2025 | investing.comPicoCELA Reports Higher Revenue and Lower Net Loss for the Fiscal Year Ended September 30, 2024February 18, 2025 | prnewswire.comPicoCELA Inc ADR PCLAFebruary 11, 2025 | morningstar.comPicocela Inc trading resumesFebruary 6, 2025 | msn.comPicocela Inc trading halted, volatility trading pauseFebruary 6, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCYTR, FGM, PCLA, and FPA Company DescriptionsLadRx NASDAQ:CYTRLadRx Corp. is a biopharmaceutical research and development company, which engages in the discovery, research, and clinical development of novel anti-cancer drug candidates. It focuses on developing the Linker Activated Drug Release (LADR) technology platform, a discovery engine to help create a pipeline of anti-cancer molecules that will avoid unacceptable systemic toxicity while delivering highly potent agents directly to the tumor. The company was founded in 1985 and is headquartered in Los Angeles, CA.First Trust Germany AlphaDEX Fund NASDAQ:FGM$54.72 -0.35 (-0.64%) As of 05/28/2025 03:59 PM EasternThe First Trust Germany AlphaDEX Fund (FGM) is an exchange-traded fund that is based on the NASDAQ AlphaDEX Germany index. The fund tracks a tiered equal-weighted index of 40 companies selected from the S&P Germany BMI based on the S&P's AlphaDex selection methodology. FGM was launched on Feb 14, 2012 and is managed by First Trust.First Trust Asia Pacific ex-Japan AlphaDEX Fund NASDAQ:FPA$32.28 +0.13 (+0.40%) As of 05/28/2025 11:28 AM EasternThe First Trust Asia Pacific Ex-Japan AlphaDEX Fund (FPA) is an exchange-traded fund that mostly invests in total market equity. The fund selects and weights 100 stocks from the S&P Asia Pacific Ex-Japan BMI Index based on their growth and value factors. FPA was launched on Apr 18, 2011 and is managed by First Trust.Picocela NASDAQ:PCLA$0.82 +0.12 (+17.97%) As of 05/28/2025 03:59 PM EasternPicoCELA, Inc. engages in the manufacturing, installation, and services for enterprise wireless mesh solutions. It also offers wireless multi-hop relay devices. The company was founded by Hiroshi Furukawa on August 8, 2008 and is headquartered in Tokyo, Japan. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Toyota Supercharges Joby: $250M Capital Infusion Ignites Stock GameStop Buys Bitcoin: Smart Strategy or Big Mistake? Qualcomm Stock Turns South: 3 Entry Signals to Watch For D-Wave Quantum Stock: Are Advantage2 Gains Here to Stay? Meta's Institutional & Insider Data Fuels Bulls Despite Disparity Is Michael Burry Right Betting Against the Market Again? Amer Sports: The New ONON and DECK of Consumer Discretionary? BigBear.ai: Risky AI Stock or Defense Tech Opportunity? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
